The company is a Korea-based company principally engaged in the medical device business. The Company is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products. The Company was established on May 23, 2003. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on September 27, 2021.
Headquarters
Seongnam Woolim Lions Valley 2 Cha A Dong 1801 And 1802 Ho, Sagimakgol-Ro 45Th Street 14, Jungwon-Gu
Seongnam; Gyeonggi;
Contact Details: Purchase the Bioplus Co., Ltd. report to view the information.
Website: http://bioplus.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service